|
Authors | BMPs | Carrier | Models | Combination delivery | Ratio (VEGF/BMP) | Bone formation in combined delivery group |
|
Kakudo et al. 2006 [41] | BMP2 | Collagen | Rat Intramuscular (3 weeks) | Simultaneous | 1 : 2 | Enhanced (compared to BMP2 alone) [41] |
|
Patel et al. 2008 [42] | BMP2 | Gelatin | Rat Calvarial defect (4/12 weeks) | Simultaneous | 6 : 1 | Enhanced at 4 weeks (compared to BMP2 alone) No significant difference at 12 weeks (compared to BMP2 alone) [42] |
|
Kempen et al. 2009 [43] | BMP2 | PLGA-BMP2 (sustained release) Gelatin-VEGF (fast release) | Rat Subcutaneous (8 weeks) Segmental femoral defect (8 weeks) | Sequential | 1 : 3.3 | Ectopic: enhanced (compared to BMP2 alone) Orthotopic: no significant difference (compared to BMP2 alone) [43] |
|
Young et al. 2009 [44] | BMP2 | Gelatin | Rat Calvarial defect (12 weeks) | Simultaneous | 6/12/24 : 1 | No significant difference (compared to BMP2 alone) [44] |
|
Roldán et al. 2010 [45] | BMP7 | BCP scaffold (growth factors injected in the scaffolds) | Mice Subcutaneous (12 weeks) | Simultaneous | 2 : 5 | No significant difference (compared to BMP7 alone) [45] |
|
Zhang et al. 2011 [7] | BMP2 | Silk hydrogels | Rabbits Sinus floor elevation model (4/12 weeks) | Simultaneous
| 2 : 3 | Enhanced (compared to BMP2 alone) [7] |
|
Geuze et al. 2012 [13] | BMP2 | PLGA-VEGF/BMP2 (fast release) Gelatin-VEGF/BMP2 (sustained release) | Dog Ectopic: intramuscular (9 weeks) Orthotopic site: ulnar defect (9 weeks) | Sequential or simultaneous | 1 : 30 | No significant enhancement effect (compared to BMP2 alone) [13] |
|
Hernández et al. 2012 [46] | BMP2 | PLGA | Rabbit Intramedullary femur defect (4/12 weeks) | Simultaneous | 1 : 10/50 | Enhanced at 4 weeks (compared to BMP2 alone) No significant difference at 12 weeks (compared to BMP2 alone) [46] |
|
Das et al. 2015 [47] | BMP6 | PLGA | Rat Mandibular defect (2/8/12 weeks)
| Simultaneous | 1 : 1 | Enhanced (compared to BMP6 alone) [47] |
|
Lv et al. 2015 [48] | BMP2 | Fibrin glue (fast release) | Rabbit Femoral condyle defect (4 weeks) | Simultaneous | 1 : 100 | No synergistic effect (compared to BMP2 alone) [48] |
|